参考文献
[1]Jakymiw A, Pauley KM, Li S, et al.The role of GW/P-bodies in RNA processing and silencing[J].Journal of cell science, 2007, 120(8):1317—1323.
[2]Bhanji RA, Eystathioy T, Chan EK, et al.Clinical and serological features of patients with autoantibodies to GW/P bodies[J].Clinical Immunology, 2007, 125(3): 247—256.
[3]Eystathioy T, Chan EK, Takeuchi K, et al.Clinical and serological associations of autoantibodies to GW bodies and a novel cytoplasmic autoantigen GW182[J].Journal of molecular medicine, 2003, 81(12): 811—818.
[4]Chan EK, Fritzler MJ.Ten Years of Progress in GW/P Body Research[M].Berlin: Springer, 2013.
[5]Moser JJ, Chan EK, Fritzler MJ.Optimization of immunoprecipitation-western blot analysis in detecting GW182—associated components of GW/P bodies[J].Nature protocols, 2009, 4(5): 674—685.
[6]Selak S, Chan EK, Schoenroth L, et al.Early endosome antigen.1: An autoantigen associated with neurological diseases[J].Journal of investigative medicine: the oき cial publication of the American Federation for Clinical Research, 1999, 47(6): 311—318.
[7]Griffith KJ, Ryan JP, Senécal JL, et al.The cytoplasmic linker protein CLIP-170 is a human autoantigen[J].Clinical & Experimental Immunology, 2002, 127(3): 533—538.
[8]Stinton LM, Swain M, Myers RP, et al.Autoantibodies to GW bodies and other autoantigens in primary biliary cirrhosis[J].Clinical &Experimental Immunology, 2011, 163(2): 147—156.
[9]Koike T.Anticardiolipin antibody and β2—glycoprotein Ⅰ[J].Clinical immunology and immunopathology (Print), 1994, 72(2): 187—192.
[10]Selak S, Mahler M, Miyachi K, et al.Identif ication of the B-cell epitopes of the early endosome antigen 1 (EEA1)[J].Clinical Immunology,2003, 109(2): 154—164.
[11]Heinlen LD, Ritterhouse LL, McClain MT, et al.Ribosomal P autoantibodies are present before SLE onset and are directed against non-Cterminal peptides[J].Journal of Molecular Medicine, 2010, 88(7): 719—727.
[12]Yoshio T, Hirata D, Onda K, et al.Antiribosomal P protein antibody in cerebrospinal f luid are associated with neuropsychiatric systemic lupus erythematosus[J].The Journal of Rheumatology, 2005, 32(1): 34—39.
[13]do Nascimento AP, dos Santos Trindade Viana V, de Abreu Testagrossa L, et al.Antibodies to ribosomal P proteins: a potential serologic marker for lupus membranous glomerulonephritis[J].Arthritis & Rheumatism: Oき cial Journal of the American College of Rheumatology, 2006, 54(5):1568—1572.
[14]Ohira H, Takiguchi J, Rai T, et al.High frequency of anti-ribosomal P antibody in patients with systemic lupus erythematosus-associated hepatitis[J].Hepatology research, 2004, 28(3): 137—139.
[15]Hamaguchi Y, Fujimoto M, Matsushita T, et al.Common and distinct clinical features in adult patients with anti-aminoacyl-tRNA synthetase antibody: heterogeneity within the syndrome[J].PloS one, 2013, 8(4): e60442.
[16]Marie I, Josse S, Decaux O, et al.Comparison of long-term outcome between anti-Jo1—and anti-PL7/PL12 positive patients with antisynthetase syndrome[J].Autoimmunity reviews, 2012, 11(10): 739—745.
[17]Hervier B, Devilliers H, Stanciu R, et al.Hierarchical cluster and survival analyses of antisynthetase syndrome: phenotype and outcome are correlated with anti-tRNA synthetase antibody specif icity[J].Autoimmunity reviews, 2012, 12(2): 210—217.
[18]Allenbach Y, Mammen AL, Benveniste O, et al.224th ENMC International Workshop: Clinico-sero-pathological classif ication of immunemediated necrotizing myopathies Zandvoort, The Netherlands, 14—16 October 2016[J].Neuromuscular Disorders, 2018, 28(1): 87—99.
[19]Lundberg IE, Tjarnlund A, Bottai M, et al.2017 European League Against Rheumatism/American College of Rheumatology classif ication criteria for adult and juvenile idiopathic inf lammatory myopathies and their major subgroups[J].Arthritis & Rheumatology, 2017, 69(12): 2271—2282.
[20]Ghirardello A, Zampieri S, Tarricone E, et al.Cutting edge issues in polymyositis[J].Clinical reviews in allergy & immunology, 2011, 41(2): 179—189.
[21]Hirakata M.Autoantibodies to aminoacyl-tRNA synthetases[J].Internal medicine, 2005, 44(6): 527—528.
[22]Lega JC, Fabien N, Reynaud Q, et al.The clinical phenotype associated with myositis-specif ic and associated autoantibodies: a meta-analysis revisiting the so-called antisynthetase syndrome[J].Autoimmunity reviews, 2014, 13(9): 883—891.